ResearcherUniversity of PennsylvaniaActive in the last 2 years
Mamta Gupta
Matched on ORCID iD 0000-0003-0928-1104; OpenAlex author ID A5005556148. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper
Papers 4
- Co-Clinical Evaluation of Synthetic Vitamin D and Chemotherapy in Pancreatic Cancer by Integrated Imaging and Molecular Analyses. Co-author DOI 10.1158/2767-9764.crc-26-0443↗
- Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy. Co-author DOI 10.1158/1078-0432.ccr-24-4049↗
- Effect of Stroma-directed Drugs in Combination with Chemotherapy Against Pancreatic Cancer- a Preclinical Study Co-author DOI 10.1101/2024.12.24.630138↗
- DWI Metrics Differentiating Benign Intraductal Papillary Mucinous Neoplasms from Invasive Pancreatic Cancer: A Study in GEM Models. Co-author DOI 10.3390/cancers14164017↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Rong Zhou · 4 shared papers, 2022–2026 · strength 0.77
- Paper Co-Clinical Evaluation of Synthetic Vitamin D and Chemotherapy in Pancreatic Cancer by Integrated Imaging and Molecular… DOI 10.1158/2767-9764.crc-26-0443↗
- Paper Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy. DOI 10.1158/1078-0432.ccr-24-4049↗
- Paper Effect of Stroma-directed Drugs in Combination with Chemotherapy Against Pancreatic Cancer- a Preclinical Study DOI 10.1101/2024.12.24.630138↗
- Mark Alan Rosen · 4 shared papers, 2022–2026 · strength 0.77
- Paper Co-Clinical Evaluation of Synthetic Vitamin D and Chemotherapy in Pancreatic Cancer by Integrated Imaging and Molecular… DOI 10.1158/2767-9764.crc-26-0443↗
- Paper Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy. DOI 10.1158/1078-0432.ccr-24-4049↗
- Paper Effect of Stroma-directed Drugs in Combination with Chemotherapy Against Pancreatic Cancer- a Preclinical Study DOI 10.1101/2024.12.24.630138↗
- Stephen Pickup · 4 shared papers, 2022–2026 · strength 0.77
- Paper Co-Clinical Evaluation of Synthetic Vitamin D and Chemotherapy in Pancreatic Cancer by Integrated Imaging and Molecular… DOI 10.1158/2767-9764.crc-26-0443↗
- Paper Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy. DOI 10.1158/1078-0432.ccr-24-4049↗
- Paper Effect of Stroma-directed Drugs in Combination with Chemotherapy Against Pancreatic Cancer- a Preclinical Study DOI 10.1101/2024.12.24.630138↗
- Peter James O'Dwyer · 3 shared papers, 2022–2026 · strength 0.54
- Paper Co-Clinical Evaluation of Synthetic Vitamin D and Chemotherapy in Pancreatic Cancer by Integrated Imaging and Molecular… DOI 10.1158/2767-9764.crc-26-0443↗
- Paper Effect of Stroma-directed Drugs in Combination with Chemotherapy Against Pancreatic Cancer- a Preclinical Study DOI 10.1101/2024.12.24.630138↗
- Paper DWI Metrics Differentiating Benign Intraductal Papillary Mucinous Neoplasms from Invasive Pancreatic Cancer: A Study in… DOI 10.3390/cancers14164017↗
- Thomas Benjamin Karasic · 3 shared papers, 2022–2026 · strength 0.54
- Paper Co-Clinical Evaluation of Synthetic Vitamin D and Chemotherapy in Pancreatic Cancer by Integrated Imaging and Molecular… DOI 10.1158/2767-9764.crc-26-0443↗
- Paper Effect of Stroma-directed Drugs in Combination with Chemotherapy Against Pancreatic Cancer- a Preclinical Study DOI 10.1101/2024.12.24.630138↗
- Paper DWI Metrics Differentiating Benign Intraductal Papillary Mucinous Neoplasms from Invasive Pancreatic Cancer: A Study in… DOI 10.3390/cancers14164017↗
- Samantha B. Kemp · 1 shared paper, 2025 · strength 0.23
- Margo Orlen · 1 shared paper, 2025 · strength 0.23
- Ben Z. Stanger · 1 shared paper, 2025 · strength 0.23
- Fang Liu · 1 shared paper, 2024 · strength 0.18
- Jianbo Cao · 1 shared paper, 2022 · strength 0.12
- Miguel Romanello Joaquim · 1 shared paper, 2022 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.